T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

NCT01142674 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1650

Last updated 2019-07-08

No results posted yet for this study

Summary

The designed study follows up the retrospective previous one by the International T-cell Non-Hodgkin's Lymphoma Study Group (International Peripheral T-Cell Lymphoma Project).

It is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed patients with the more frequent subtypes of Peripheral T-cell lymphoma (Peripheral T-cell lymphoma unspecified and Angioimmunoblastic T-cell lymphoma) and to better define clinical characteristics and outcome of the more uncommon subtypes

Conditions

  • Lymphoma, T-Cell, Peripheral

Sponsors & Collaborators

  • Fondazione Italiana Linfomi - ETS

    collaborator OTHER
  • INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA STUDY GROUP

    collaborator UNKNOWN
  • Associazione Angela Serra per la ricerca sul cancro

    lead OTHER

Principal Investigators

  • Massimo Federico, MD · Dip. Medicina Diagnostica - Università di Modena e Reggio Emilia, , Modena, IT

  • Julie M. Vose, MD · Nebraska Medical Center, Omaha, NE, USA

  • Emanuele Zucca, MD · IOSI/Oncology Institute of Southern Switzerland, Ospedale S. Giovanni - Bellinzona, CH

  • Joseph M Connors, MD · British Columbia Cancer Agency, Vancouver, CA

  • Steven M. Horwitz, MD · Memorial Sloan Kettering Cancer Center

  • Francine M. Foss, MD · Yale Cancer Center, New Haven, CT, USA

  • Pier Luigi Zinzani, MD · Istituto di Ematologia e Oncologia Medica "L. e A. Seragnoli", Policlinico Sant'Orsola, Bologna, IT

  • Silvia Montoto, MD · St. Bartholomew Hospital, London, UK

  • Aaron Polliack, MD · Sourasky Medical Center, Tel Aviv, IL

  • Stefano A. Pileri, MD · Università di Bologna, IT & Istituto Europeo di Oncologia, Milano, IT

  • Young H. Ko, MD · Samsung Medical Center, Seoul, KR

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2016-07-31
Completion
2018-12-31

Countries

  • United States
  • Argentina
  • Brazil
  • Chile
  • China
  • France
  • Israel
  • Italy
  • Slovakia
  • South Korea
  • Spain
  • Switzerland
  • United Kingdom
  • Uruguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01142674 on ClinicalTrials.gov